New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
09:36 EDTTWTR, GILD, LVS, AAPL, ABXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD ABX LVS TWTR
News For AAPL;GILD;ABX;LVS;TWTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
April 7, 2015
09:52 EDTAAPLApple retail chief instructs staff to push Apple Store shoppers online, BI says
Apple retail chief Angela Ahrendts wants staff at Apple Stores to push customers to order the Apple Watch and the new MacBook online instead of buying in physical stores, Business Insider reports, citing a memo. The memo notes that "This is a significant change in mindset" and will help ensure guaranteed delivery of the Apple products. Reference Link
09:35 EDTAAPL, TWTRActive equity options trading on open
Subscribe for More Information
06:46 EDTAAPLApple Pay, Google Wallet could see competition from CurrentC, Macworld says
Subscribe for More Information
06:25 EDTAAPLMicrosoft close to have alternative to Apple Pay, Business Insider reports
Subscribe for More Information
06:19 EDTAAPLApple quietly acquired Ottocat 'some time ago,' TechCrunch reports
Apple quietly bought Ottocat, a startup that has developed a system to organize apps on its app store based on "nested" categories, TechCrunch reports. Terms of the acquisition, which is said to have closed "some time ago," have not been disclosed. A version of Ottocat's system currently powers the "explore" tab in Apple's App Store, TechCrunch says. Reference Link
06:00 EDTTWTRTurkey restores access to YouTube, Twitter, Facebook, FT reports
Subscribe for More Information
April 6, 2015
19:42 EDTAAPLSurvey of iPhone, iPad users indicates preference for Google search, BI says
48% of Apple (AAPL) iPhone and iPad users report that if Yahoo (YHOO) were to acquire default search engine rights for Apple's Safari browser, they would manually switch the default search back to Google (GOOG), reports Business Insider, citing a survey of roughly 500 Apple users by Goldman Sachs tech analysts. 4% of the surveyed users stated they would intentionally keep Yahoo as the default. Reference Link
16:00 EDTAAPL, TWTROptions Update; April 6, 2015
iPath S&P 500 VIX Short-Term Futures down 51c to 24.53. Option volume leaders: AAPL TSLA VZ TWTR BIDU RIG NFLX AMZN KO PBR according to Track Data.
11:30 EDTTWTROptions with increasing implied volatility
Subscribe for More Information
10:23 EDTAAPLApple Maps searches no longer showing just Yelp, AppleInsider reports
Searches on Apple (AAPL) Maps, which previously relied solely on Yelp (YELP) to provide reviews for local search, are now pulling results from TripAdvisor (TRIP) and Priceline's (PCLN) Booking.com, AppleInsider reported yesterday. Neither TripAdvisor or Booking.com are listed as sources on Apple's official Maps attribution webpage, but reviews with links to their respective webpages and apps are now appearing in Maps queries, the blog added. Shares of Yelp are down 1% to $46.67 in early trading. Reference Link
09:36 EDTAAPL, ABXActive equity options trading on open
Subscribe for More Information
09:04 EDTTWTRTwitter says 'aware of reports of interruption of service in Turkey'
Subscribe for More Information
07:36 EDTGILDGilead Q1 HCV revenue poised to beat expectations, says RBC Capital
After analyzing weekly prescription data, RBC Capital believes that Gilead's weekly hepatitis C prescriptions are tracking towards $3.5B-$3.6B of revenue from hepatitis C drugs for Q1, versus the consensus outlook of about $2.6B. The firm keeps an Outperform rating on Gilead.
07:29 EDTAAPLApple Watch cannot launch in Switzerland due to patent issue, Reuters says
Subscribe for More Information
06:20 EDTAAPLGarmin downgraded to Sell from Buy at Citigroup
Citigroup analyst Jeremy David downgraded Garmin two notches to Sell from Buy saying competitive pressures are likely to stall the growth of the company's GPS fitness watch business. He also thinks revenue trends in Garmin's Outdoor segment could disappoint as the year progresses. David expects Garmin to miss consensus earnings and revenue expectations in Q1 and views the Apple (AAPL) Watch launch as another potential negative catalyst for shares. He cut his price target for the stock to $42 from $68. Shares of the navigation and information device maker closed Thursday down 58c to $46.49 after Goldman Sachs downgraded the stock Neutral from Buy.
06:11 EDTAAPLSamsung expected to win A9 chip orders for next iPhone, Bloomberg reports
Subscribe for More Information
05:54 EDTABXBarrick Gold Chairman open to sell-offs and joint ventures, Financial Times says
Barrick Gold is set to open a range of asset sales and joint ventures as it looks to cut its debt by $3B, reports the Financial Times. Chairman John Thornton said in an interview that he could imagine Barrick Gold ceding operational control of some assets while bringing long-term investors into a group of its mines as minority partners. Reference Link
April 5, 2015
16:56 EDTAAPLEU considers major probe into Internet platforms, WSJ says
Subscribe for More Information
14:43 EDTGILDActavis seeks FDA approval to market generic version of Gilead's Letairis
Actavis (ACT) on Friday, confirmed that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Ambrisentan Tablets, 5 mg and 10 mg. Actavis' ANDA product is a generic version of Gilead Science's (GILD) Letairis, which is a treatment for pulmonary arterial hypertension. Gilead Sciences and Royalty Pharma Collection Trust filed suit against Actavis on April 1, in the U.S. District Court for the District of Delaware seeking to prevent Actavis from commercializing its ANDA product prior to the expiration of U.S. Patent number RE42,462. The lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Actavis' ANDA for up to 30 months from the date the plaintiffs received notice of Actavis' ANDA filing or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities. Based on available information, Actavis believes it may be a "first applicant" to file an ANDA for the generic version of Letairis and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity. For the 12 months ending December 31, Letairis had global sales of approximately $595M, according to Gilead.
09:10 EDTAAPLApple Watch to be sold by appointment only, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use